Understanding Your Diagnosis: Autosomal Dominant Epidermolytic Ichthyosis (EI)
At a Glance
Autosomal dominant epidermolytic ichthyosis is caused by KRT1 or KRT10 mutations. It often begins with redness and blistering in infancy, then shifts toward thickened, scaly skin; genetic testing and sometimes biopsy help confirm the diagnosis and guide care.
Autosomal dominant epidermolytic ichthyosis (EI) is a rare genetic skin condition that belongs to a group of disorders known as keratinopathic ichthyoses [1]. If you or your child has been diagnosed with EI, it means the skin lacks the structural “scaffolding” it needs to stay strong and intact. While the diagnosis can feel overwhelming, understanding how the condition generally changes over time can help you prepare for the different phases of care.
The Biology: A Breakdown in the Scaffolding
Your skin is made of layers of cells that rely on proteins called keratins to provide strength and resilience [2]. In EI, mutations in the KRT1 or KRT10 genes disrupt the production of these proteins [3].
Think of keratins like the steel rebar in a concrete building. In a healthy person, keratin 1 and keratin 10 link together to form a sturdy network of intermediate filaments—fine, hair-like structures that give the skin cells their shape and toughness [4]. In EI, these filaments don’t assemble correctly. Instead, they may collapse or form clumps (aggregates) inside the cells [5]. This makes the top layer of skin extremely fragile; even minor friction or pressure can cause the cells to break apart, leading to the characteristic blistering and redness seen in this condition [2].
The Two-Phase Pattern of EI
One of the most confusing aspects of EI is that it often looks very different in a newborn than it does in an adult. Doctors often describe this as a “two-phase” clinical pattern, though it is not a strict or universal rule [6]:
- The Early Phase (Birth and Infancy): Most babies with EI are born with erythroderma (intense skin redness) and widespread, superficial blistering [7]. At this stage, the skin is so delicate that it may peel or erode easily, leaving raw areas that require careful protection and wound care [8].
- The Transition Phase (Childhood to Adulthood): As a person ages, the frequent blistering and redness typically begin to decrease (though blisters can still occur). In their place, the skin starts to overproduce cells in an attempt to protect itself, leading to hyperkeratosis—a significant thickening of the skin [6]. These thick, verrucous (very thickened) scales typically develop in the creases of the elbows and knees, around the neck, and sometimes across the entire body [7].
Understanding Your Specific Type
While all EI involves KRT1 or KRT10 mutations, the specific gene involved can influence how the condition shows up:
- KRT1 Mutations: These tend to be more frequently associated with palmoplantar keratoderma, which is a severe thickening of the skin on the palms of the hands and the soles of the feet [9].
- KRT10 Mutations: Patients with KRT10 mutations often have a wider range of symptoms, from mild to severe, and they are generally less likely to have severe hand and foot thickening compared to KRT1 cases [10].
Validating the Daily Burden
Living with EI is a major commitment. Research shows that the daily routine of bathing, moisturizing, and managing scales is a significant weight for families. In one observational study of 48 people living with EI, 78% reported that their daily life was restricted by the time and effort required for their care and therapies [9].
Beyond the time spent on treatments, many patients deal with invisible symptoms. In that same 48-person cohort, approximately half experienced chronic, severe pain and itching [9]. It is important to acknowledge that the emotional and physical energy required to manage this condition is substantial. You are not just managing a skin condition; you are navigating a complex daily routine that impacts school, work, and family life.
Confirming the Diagnosis
Because EI can look like other blistering conditions at birth, doctors use a combination of tools:
- Genetic Testing: Using a multi-gene panel is usually the preferred method to identify the exact KRT1 or KRT10 mutation [11].
- Skin Biopsy: A doctor may take a small sample of skin to look for epidermolytic hyperkeratosis, a specific pattern of cell breakdown under a microscope [12]. However, it is important to know that this pattern isn’t always visible in the first week of life, so a “normal” early biopsy doesn’t rule out EI [13].
Common questions in this guide
What causes autosomal dominant epidermolytic ichthyosis?
Why can EI change from blistering in infancy to thick skin later?
Which tests confirm epidermolytic ichthyosis?
How do KRT1 and KRT10 mutations affect symptoms?
How can EI affect everyday family life?
What does daily skin care for EI usually involve?
Get notified when new evidence is published on Autosomal dominant epidermolytic ichthyosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Expanding the Clinical and Genetic Spectrum of KRT1, KRT2 and KRT10 Mutations in Keratinopathic Ichthyosis.
Hotz A, Oji V, Bourrat E, et al.
Acta dermato-venereologica 2016; (96(4)):473-8 doi:10.2340/00015555-2299.
PMID: 26581228 - 2
Variants in the L12 linker domain of KRT10 are causal to atypical epidermolytic ichthyosis.
van der Velden JJAJ, van Gisbergen MW, Kamps MAF, et al.
The Journal of dermatology 2024; (51(9)):1180-1186 doi:10.1111/1346-8138.17395.
PMID: 39072839 - 3
Gene Editing-Mediated Disruption of Epidermolytic Ichthyosis-Associated KRT10 Alleles Restores Filament Stability in Keratinocytes.
March OP, Lettner T, Klausegger A, et al.
The Journal of investigative dermatology 2019; (139(8)):1699-1710.e6 doi:10.1016/j.jid.2019.03.1146.
PMID: 30998984 - 4
Epidermolytic Ichthyosis Sine Epidermolysis.
Eskin-Schwartz M, Drozhdina M, Sarig O, et al.
The American Journal of dermatopathology 2017; (39(6)):440-444 doi:10.1097/DAD.0000000000000674.
PMID: 28121638 - 5
Mutations Affecting Keratin 10 Surface-Exposed Residues Highlight the Structural Basis of Phenotypic Variation in Epidermolytic Ichthyosis.
Mirza H, Kumar A, Craiglow BG, et al.
The Journal of investigative dermatology 2015; (135(12)):3041-3050 doi:10.1038/jid.2015.284.
PMID: 26176760 - 6
Epidermolytic ichthyosis in a child and systematized epidermolytic nevi in the mosaic parent associated with a KRT1 variant.
Chia SY, Tan EC, Wei H, et al.
European journal of medical genetics 2021; (64(11)):104324 doi:10.1016/j.ejmg.2021.104324.
PMID: 34461324 - 7
Unilateral hyperkeratotic plaques along blaschko lines.
Kumar P, Debbarman P, Rk S
Dermatology online journal 2015; (21(7)).
PMID: 26436980 - 8
Management of Epidermolytic Ichthyosis in the Newborn.
Avril M, Riley C
Neonatal network : NN 2016; (35(1)):19-28 doi:10.1891/0730-0832.35.1.19.
PMID: 26842536 - 9
Epidermolytic ichthyosis: Clinical spectrum and burden of disease in a large German cohort.
Frommherz L, Giehl K, Hofmann J, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(5)):1028-1037 doi:10.1111/jdv.20096.
PMID: 38741524 - 10
Novel and recurrent mutations in keratin 1 cause epidermolytic ichthyosis and palmoplantar keratoderma.
Smith FJD, Kreuser-Genis IM, Jury CS, et al.
Clinical and experimental dermatology 2019; (44(5)):528-534 doi:10.1111/ced.13800.
PMID: 30288772 - 11
Generalized epidermolytic ichthyosis with palmoplantar hyperkeratosis.
Putra PB, Radiono S, Danarti R
Dermatology online journal 2021; (27(2)).
PMID: 33818988 - 12
Inherited ichthyosis: Non-syndromic forms.
Takeichi T, Akiyama M
The Journal of dermatology 2016; (43(3)):242-51 doi:10.1111/1346-8138.13243.
PMID: 26945532 - 13
Two cases of KRT1 mutation-associated epidermolytic ichthyosis without typical epidermolytic hyperkeratosis in the neonatal skin lesions.
Kim T, Kim SC, Lee SE
Pediatric dermatology 2023; (40(6)):1149-1151 doi:10.1111/pde.15354.
PMID: 37170713
This page is for informational purposes only and does not constitute medical advice. A dermatologist or genetics professional should interpret your or your child’s results and recommend an individualized care plan.